The CEO address to shareholders: We have adjusted our strategytowards a “compliance listing”, which is now expected to occur during Februaryand will coincide with the release of results from our IHL-42X phase 2 clinicalstudy.
Some were askingabout a “Compliance Listing”. A compliance listing means a listing on theNasdaq without an attaching capital raise at the time trading starts.
Since that timeIncannex have withdrawn their F-1 application on the Nasdaq and this was one factorin the downturn of the share price.
To list in February the BOD will need to havea new application submitted to the Nasdaq as the F-1 application was withdrawn.In my opinion - Thiswould have to be done ASAP for a February listing. Maybe a new application will be listedwith sec within a few days. Maybe a 20-F application.
Wilsde
